Curesponse

Curesponse is a medical company dedicated to developing three-dimensional tissue culture systems for modeling cancer growth and drug response. The company's technology represents the next step in personalized cancer medicine, shifting predictive capabilities from the field of genomics to the functional responses of patients' living cells. The platform preserves cancer tissue structures, including blood vessels and the immune system, accurately reflecting cancer growth found in the body. The company’s platform, cResponse, is a functional cancer diagnostic tool that maintains patient tumors in 3D form for up to two weeks, allowing observation of the cancer microenvironment’s response to cancer therapies. By suggesting the best drug options for each patient, the platform provides clinicians and patients with critical and actionable information, which can potentially save lives, reduce treatment costs, and assist in the development of clinical trials as a companion diagnostic tool for pharmaceutical companies.